Companies/US/TVGN

TEVOGEN BIO HOLDINGS INC.

Last · NasdaqGM$6.506-0.6044 (-8.50%)close · yahoo · 14h ago
Vol 2.5K ≈ 16.2K
Market cap$42.36M6.5M sh
P/E · TTM-1.0fwd — · eps -6.74 · loss
Beta0.20vs S&P 500
Div yield0.00%annual · TTM
52w range
$3.636$39.00
Volume2.5Ksession

Issuer

Legal nameTEVOGEN BIO HOLDINGS INC.
HQUnited States (US)
ListingUS TVGN
ISINUS88165K2006
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001860871
CIK0001860871
Employees18
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-03-31

From latest 10-K · 2026-03-31

  • Operating Cf Burn
  • Cash Runway Low
  • Current Ratio Low

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Cash Runway Low — Cash runway ~0.0 years
  • Current Ratio Low — Current ratio 0.22

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0

Press & signals

3 of 4 recent
  • GlobeNewswire

    UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC

  • GlobeNewswire

    Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC

  • GlobeNewswire

    Tevogen Bio Holdings Inc. Becomes Tevogen Inc.

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
2026-09-142026-09-160
2026-09-142026-09-160
2026-09-112026-09-150